Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    CLN-081

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taiho Oncology, Cullinan Therapeutics Present Zipalertinib Data
    Taiho Oncology, Cullinan Therapeutics Present Zipalertinib Data

    13 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-present-data-on-zipalertinib-in-patients-with-nsclc-with-egfr-mutations-and-active-brain-metastases-at-the-esmo-congress-2025-302581514.html

    PR NEWSWIRE
    13 Oct 2025
    Share Share
    Cullinan, Taiho's NSCLC Shows 'Strong Activity', Paves Way to FDA
    Cullinan, Taiho's NSCLC Shows 'Strong Activity', Paves Way to FDA

    10 Sep 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/cullinan-taihos-nsclc-hopeful-shows-strong-activity-clearing-road-to-fda

    BIOSPACE
    10 Sep 2025
    Share Share
    Taiho & Cullinan Present Zipalertinib Data at IASLC Conference
    Taiho & Cullinan Present Zipalertinib Data at IASLC Conference

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-present-data-on-zipalertinib-at-the-iaslc-2025-world-conference-on-lung-cancer-302549926.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    Taiho Oncology's Zipalertinib Abstract Accepted for ESMO
    Taiho Oncology's Zipalertinib Abstract Accepted for ESMO

    25 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-announces-acceptance-of-abstract-for-zipalertinib-at-the-esmo-congress-2025-302513640.html

    PR NEWSWIRE
    25 Jul 2025
    Share Share
    Taiho Oncology, Cullinan Therapeutics' Zipalertinib abstracts
    Taiho Oncology, Cullinan Therapeutics' Zipalertinib abstracts

    22 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-announce-acceptance-of-abstracts-for-zipalertinib-at-the-iaslc-2025-world-conference-on-lung-cancer-302510269.html

    PR NEWSWIRE
    22 Jul 2025
    Share Share
    Taiho & Cullinan Announce Phase 1/2 Data Published
    Taiho & Cullinan Announce Phase 1/2 Data Published

    01 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-announce-pivotal-rezilient1-phase-12-data-published-in-the-journal-of-clinical-oncology-302470143.html

    PR NEWSWIRE
    01 Jun 2025
    Share Share